XML 79 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Revenue
3 Months Ended
Mar. 31, 2020
Revenue  
Revenue

(4) Revenue

(a)Disaggregation of Revenue

Revenue is disaggregated by type in the following table. The table also identifies which reportable segment that the disaggregated revenues relate. For more information on reportable segments, see Note 17— Segment Information.

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended March 31,

​

Segment to which

​

(in thousands)

   

2019

   

2020

   

revenues relate

   

Revenues from contracts with customers:

​

​

​

​

​

​

​

​

​

Natural gas sales

​

$

657,266

​

​

411,082

​

Exploration and production

​

Natural gas liquids sales (ethane)

​

​

35,516

​

​

26,796

​

Exploration and production

​

Natural gas liquids sales (C3+ NGLs)

​

​

278,169

​

​

230,877

​

Exploration and production

​

Oil sales

​

​

48,052

​

​

35,646

​

Exploration and production

​

Gathering and compression (1)

​

​

3,972

​

 

—

​

Equity method investment in AMC

​

Water handling and treatment (1)

​

​

507

​

​

—

​

Equity method investment in AMC

​

Marketing

​

​

91,186

​

​

46,073

​

Marketing

​

Total revenue from contracts with customers

​

​

1,114,668

​

 

750,474

​

​

​

Income (loss) from derivatives and other sources:

​

​

(77,261)

​

​

566,631

​

​

​

Total revenue and other

​

$

1,037,407

​

​

1,317,105

​

​

​

(1)Gathering and compression and water handling and treatment revenues were included through March 12, 2019. See Note 3 to the unaudited condensed consolidated financial statements for further discussion on the Transactions.

​

(b)Transaction Price Allocated to Remaining Performance Obligations

For our product sales that have a contract term greater than one year, we have utilized the practical expedient, which does not require the disclosure of the transaction price allocated to remaining performance obligations if the variable consideration is allocated entirely to a wholly unsatisfied performance obligation. Under our product sales contracts, each unit of product delivered to the customer represents a separate performance obligation; therefore, future volumes are wholly unsatisfied and disclosure of the transaction price allocated to remaining performance obligations is not required. For our product sales that have a contract term of one year or less, we have utilized the practical expedient, which does not require the disclosure of the transaction price allocated to remaining performance obligations if the performance obligation is part of a contract that has an original expected duration of one year or less.

(c)Contract Balances

Under our sales contracts, we invoice customers after our performance obligations have been satisfied, at which point payment is unconditional. Accordingly, our contracts do not give rise to contract assets or liabilities. At December 31, 2019 and March 31, 2020, our receivables from contracts with customers were $318 million and $201 million, respectively.